Nessan Bermingham

Overview

Nessan Bermingham received an average of $5.3M in compensation at Intellia Therapeutics from 2015 to 2017.

Source: SEC filings on April 17, 2018 and April 18, 2017.

Related executives

We found five more executives who work or worked at Intellia Therapeutics.

John Leonard

Intellia Therapeutics

Chief Executive Officer

Andrew Schiermeier

Intellia Therapeutics

Executive Vice President, Development and Corporate Strategy

José Rivera

Intellia Therapeutics

General Counsel

Glenn Goddard

Intellia Therapeutics

Chief Financial Officer

Graeme Bell

Intellia Therapeutics

Chief Financial Officer

You may also like